Infectious disease health services for refugees and asylum seekers during a time of crisis: a scoping study of six European Union countries
(Source: Health Policy)
Source: Health Policy - April 11, 2018 Category: Health Management Authors: Kayvan Bozorgmehr, Mariya Samuilova, Roumyana Petrova-Benedict, Enrico Girardi, Pierluca Piselli, Alexander Kentikelenis Source Type: research
Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands
The demand for healthcare is rapidly increasing for reasons that include ageing populations and the availability of increasingly advanced and expensive (new) health technologies. As healthcare resources remain scarce, the resulting pressure on available budgets renders healthcare priority setting inevitable [1,2]. Although politically and societally sensitive, the need for prioritisation is widely recognised and explicitly addressing priority setting has become indispensable for developing fairer methods for resource allocation in healthcare [3,4]. (Source: Health Policy)
Source: Health Policy - April 7, 2018 Category: Health Management Authors: V.T. Reckers-Droog, N.J.A. van Exel, W.B.F. Brouwer Source Type: research
Looking Back and Moving Forward: On the Application of Proportional Shortfall in Healthcare Priority Setting in the Netherlands
(Source: Health Policy)
Source: Health Policy - April 7, 2018 Category: Health Management Authors: Vivian Reckers-Droog, Job van Exel, Werner Brouwer Source Type: research
Editorial Board
(Source: Health Policy)
Source: Health Policy - April 1, 2018 Category: Health Management Source Type: research
Harnessing the private health sector by using prices as a policy instrument: Lessons learned from South Africa
Most member countries of the Organization for Economic Cooperation and Development (OECD) have implemented universal health coverage (UHC) —in that they have achieved good health outcomes through universal access to care without financial hardship [1]. Rising health care spending, however, has pressured policymakers to maximize all available health resources and reduce waste and inefficiencies. As such, governments frequently draw on the private sector to promote sustainability, optimal use of resources, and increased choice of care. (Source: Health Policy)
Source: Health Policy - March 29, 2018 Category: Health Management Authors: Sarah L. Barber, Ankit Kumar, Tomas Roubal, Francesca Colombo, Luca Lorenzoni Source Type: research
Harnessing the private health sector by using prices as a policy instrument: Lessons learned from South Africa
(Source: Health Policy)
Source: Health Policy - March 29, 2018 Category: Health Management Authors: Sarah Louise Barber, Ankit Kumar, Tomas Roubal, Francesca Colombo, Luca Lorenzoni Source Type: research
Paying hospital specialists: Experiences and lessons from eight high-income countries
The decisions, efforts and skills of specialists in hospitals lead the clinical care processes and determine to a large extent both the success of treatment and the resources used [1]. In most high-income countries, hospitals account for the largest part of health expenditures, usually between 30 and 40% of total spending [2]. Specialists control with their decisions the vast majority of these resources, e.g. by ordering diagnostic tests, prescribing drugs, and ordering and performing procedures [1,3]. (Source: Health Policy)
Source: Health Policy - March 26, 2018 Category: Health Management Authors: Wilm Quentin, Alexander Geissler, Friedrich Wittenbecher, Geoff Ballinger, Robert Berenson, Karen Bloor, Dana A. Forgione, Peer K öpf, Madelon Kroneman, Lisbeth Serden, Raúl Suarez, Johan W. van Manen, Reinhard Busse Source Type: research
Cost-effectiveness of HIV screening in high-income countries: A systematic review
In 2012, over 35 million people lived with human immunodeficiency virus (HIV) infection worldwide, and of these, approximately 2.2 million lived in high-income countries [1]. Moreover, a large percentage of the infected population are unaware of their status; for example, in the US, 21% of people living with HIV ignore this condition [2]. Knowledge of the HIV-serostatus and early treatment can improve both the survival and the quality of life of infected subjects [3]. In addition to the individual benefits, the early identification of HIV may have a role in reducing the transmission from index patients to uninfected person...
Source: Health Policy - March 26, 2018 Category: Health Management Authors: Fabrizio Bert, Maria Rosaria Gualano, Paolo Biancone, Valerio Brescia, Elisa Camussi, Maria Martorana, Silvana Secinaro, Roberta Siliquini Source Type: research
Confirmatory versus explorative endpoint analysis: Decision-making on the basis of evidence available from market authorization and early benefit assessment for oncology drugs
The efficacy, safety and quality of a new drug are considered to have been proven upon market authorization. According to the ‘Act to Reorganize the Pharmaceuticals Market in the SHI System’ (AMNOG), which came into effect on 1 January 2011, an additional benefit of new drugs based on patient-relevant outcomes has to be demonstrated for time-shifted reimbursement negotiations by means of an early benefit assessment. (Source: Health Policy)
Source: Health Policy - March 26, 2018 Category: Health Management Authors: Ines Niehaus, Charalabos-Markos Dintsios Source Type: research
Paying hospital specialists: Experiences and lessons from eight high-income countries
(Source: Health Policy)
Source: Health Policy - March 26, 2018 Category: Health Management Authors: Wilm Quentin, Alexander Geissler, Friedrich Wittenbecher, Geoff Ballinger, Robert Berenson, Karen Bloor, Dana A. Forgione, Peer K öpf, Madelon Kroneman, Lisbeth Serden, Raúl Suarez, Johan W. van Manen, Reinhard Busse Source Type: research
Cost-effectiveness of HIV screening in high-income countries: A systematic review
(Source: Health Policy)
Source: Health Policy - March 26, 2018 Category: Health Management Authors: Fabrizio Bert, Maria Rosaria Gualano, Paolo Biancone, Valerio Brescia, Elisa Camussi, Maria Martorana, Silvana Secinaro, Roberta Siliquini Source Type: research
Confirmatory versus explorative endpoint analysis: decision-making on the basis of evidence available from market authorization and early benefit assessment for oncology drugs
(Source: Health Policy)
Source: Health Policy - March 26, 2018 Category: Health Management Authors: Ines Niehaus, Charalabos-Markos Dintsios Source Type: research
Strengthening the public health workforce: An estimation of the long-term requirements for public health specialists in Serbia
At the beginning of the 21st century, planning the public health workforce requirements came into the focus of policy makers in Europe [1]. The public health workforce contributes by performing, supporting and managing essential public health operations [1,2]. They are needed to address public health challenges and to help achieving national and global health objectives such as managing epidemic ’s (or the risk of outbreaks) of communicable disease and the ever growing pressure of non-communicable disease and health related inequalities [3–10]. (Source: Health Policy)
Source: Health Policy - March 22, 2018 Category: Health Management Authors: Milena Santric Milicevic, Milena Vasic, Matt Edwards, Cristina Sanchez, John Fellows Source Type: research
The impact of pay-for-performance on the quality of care in ophthalmology: Empirical evidence from Germany
Cataract surgery has become a routine surgical procedure in most developed countries. Approximately 19 million procedures are performed every year worldwide [1], of which approximately 800,000 procedures are performed in Germany [2]. According to the WHO, it is estimated that the total number of cataract procedures will rise to 32 million by the year 2020 [1,3,4]. Different approaches aim to capture the quality of care in cataract surgery. With regard to measurement of clinical reported outcomes (CROs), clinical metrics such as visual acuity and complication rates are most frequently used. (Source: Health Policy)
Source: Health Policy - March 22, 2018 Category: Health Management Authors: T. Herbst, J. Foerster, M. Emmert Source Type: research
Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia
“Let a little bit of sunshine into this world of financial relationships − it is, after all, the best disinfectant” were United States (US) Senator Grassley’s words to the Senate in 2007 when he first introduced the Physician Payments Sunshine Act, which would mandate public disclosure of pa yments to physicians from pharmaceutical and medical device companies [1]. The Sunshine Act became law in the US in 2010, and “sunshine” has subsequently gone “global [2],” with numerous other countries, including France, Slovenia, Turkey, Australia and Japan, either adopting, or contemplati ng, “sunshine-like” legi...
Source: Health Policy - March 22, 2018 Category: Health Management Authors: Quinn Grundy, Roojin Habibi, Adrienne Shnier, Christopher Mayes, Wendy Lipworth Source Type: research
